Summary
Latest filing:
Pierre A. Morgon is Director of Barinthus Biotherapeutics plc. (BRNS). 1 SEC Form 4 filing on record, dated 9 September 2026.
Recent Transactions
1Every recent SEC Form 4 transaction Pierre A. Morgon has reported, most recent first.
Other Insiders Active in the Same Sector
No other insider has filed at Pierre A. Morgon's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Keith A. Meister - $591.13M of ILMN open-market activity in the last 12 months
- Ronda E. Stryker - $580.89M of SYK open-market activity in the last 12 months
- Mozart Aggregator II LP - $579.20M of MDLN open-market activity in the last 12 months
- TC Group VII S1, L.L.C. - $554.95M of MDLN open-market activity in the last 12 months
- BERKSHIRE HATHAWAY INC - $473.67M of DVA open-market activity in the last 12 months
- RA CAPITAL MANAGEMENT, L.P. - $430.69M of PBLS open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Pierre A. Morgon?
Pierre A. Morgon is a corporate insider, tracked as Director of Barinthus Biotherapeutics plc. (BRNS). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Pierre A. Morgon submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Where can I see all of Pierre A. Morgon's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Pierre A. Morgon and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
